1-8 of 8
Erin Jou
Close
Sort by
Journal Articles

Association between Neutropenic Index for Venetoclax Exposure (NIVE) and Survival Outcomes Among AML Patients Highlighting Racial Disparities

Phyu Thin Thin Naing, Stephanie Boisclair, Edward Zhou, Richa Thakur, Erin Jou, Bradley Goldberg, David W Chitty, Jonathan E Kolitz
Journal: Blood
Blood (2023) 142 (Supplement 1): 4219.
https://doi.org/10.1182/blood-2023-190410
Published: 2023
Journal Articles

Survival Outcomes Associated with Molecular and Cytogenetic Alterations in AML Patients Treated with Hypomethylating Agent and Venetoclax

Stephanie Boisclair, Phyu Thin Naing, Edward Zhou, Richa Thakur, Bradley Goldberg, Erin Jou, David W Chitty, Jonathan E Kolitz
Journal: Blood
Blood (2023) 142 (Supplement 1): 2904.
https://doi.org/10.1182/blood-2023-190272
Published: 2023
Journal Articles

Differences in Molecular Alterations and Clinical Outcomes By Ethnicity for Patients with Acute Myeloid Leukemia Treated with Hypomethylating Agents and Venetoclax

Edward Zhou, Stephanie Boisclair, Phyu Thin Naing, Richa Thakur, Bradley Goldberg, Erin Jou, David W Chitty, Jonathan E Kolitz
Journal: Blood
Blood (2023) 142 (Supplement 1): 7427.
https://doi.org/10.1182/blood-2023-185014
Published: 2023
Journal Articles

Outcomes and Hospital Resource Utilization Associated with Decreased Ven Exposure in Acute Myeloid Leukemia Patients: A Real-World Retrospective Review

Stephanie Boisclair, Phyu Thin Naing, Edward Zhou, Richa Thakur, Erin Jou, Bradley Goldberg, David W Chitty, Jonathan E Kolitz
Journal: Blood
Blood (2023) 142 (Supplement 1): 4268.
https://doi.org/10.1182/blood-2023-185079
Published: 2023
Journal Articles

End-of-Life Outcomes in Patients with Acute Myeloid Leukemia Receiving Non-Curative Chemotherapy

Richa Thakur, Stephanie Boisclair, Phyu Thin Naing, Edward Zhou, Bradley Goldberg, Erin Jou, Jonathan E Kolitz, David W Chitty
Journal: Blood
Blood (2023) 142 (Supplement 1): 3807.
https://doi.org/10.1182/blood-2023-190266
Published: 2023
Journal Articles

Retrospective Study of the Incidence and Risk Factors for Hematological Malignancies in Patients with Hepatitis B Virus Infection

Erin Jou, MD, Carmen KM Cheung, MBChB, MRCP, Ryan CY Ho, Diwakar Mohan, MD MPH, Uriel Felsen, MD, Henny H Billett, MD, Anthony T.C. Chan, MD FRCP, Edwin P Hui, MD FRCP, Radha Raghupathy, MD
Journal: Blood
Blood (2014) 124 (21): 5403.
https://doi.org/10.1182/blood.V124.21.5403.5403
Published: 2014
Journal Articles

The Incidence and Risk Factors For Hematological Malignancies and Premalignant Hematological Disorders In HIV

Erin Jou, MD, Oleg Gligich, MD, Alvita CY Chan, MD, Diwakar Mohan, MD, MPH, Felsen Uri, MD, Henny Heisler Billett, MD, Anthony T.C. Chan, MD, Radha Raghupathy, MD
Journal: Blood
Blood (2013) 122 (21): 4304.
https://doi.org/10.1182/blood.V122.21.4304.4304
Published: 2013
Journal Articles

Retrospective Exploratory Study of HIV+ Patients with and without Paraproteinemia for Association with HIV Status, Comorbidities and Development of Hematological Malignancies

Erin Jou, MD, Diwakar Mohan, MD, MPH, Sabarish Ayyappan, MD, Oleg Gligich, MD, Henny Heisler Billett, MD, Anthony T.C. Chan, MD, Radha Raghupathy, MD
Journal: Blood
Blood (2012) 120 (21): 1827.
https://doi.org/10.1182/blood.V120.21.1827.1827
Published: 2012